Tuesday, 11 December 2018

Nifty, Sensex May Rally a Bit More – Tuesday closing report -The Total Investment & Insurance Solutions


Contact Your Financial Adviser Money Making MC
11 December 2018
 
financial markets (The Total Investment & Insurance Solutions)
I had mentioned in Monday’s closing report that Nifty, Sensex were headed for more losses. The major indices of the Indian stock markets fell sharply in the morning and made a dramatic rally on Tuesday and closed with gains over Monday’s close. On the NSE, there were 1,249 advances, 454 declines and 356 unchanged. The trends of the major indices in the course of Tuesday’s trading are given in the table below: The Total Investment & Insurance Solutions


The market had lost significantly during the morning trade session on the sudden resignation by RBI Governor Urjit Patel and early election trends which showed BJP losing in Rajasthan and Chattisgarh state elections and trailing Congress in Madhya Pradesh.

Software major Tech Mahindra on Tuesday announced key leadership appointments in India to accelerate its digital transformation. The leadership changes will be effective from January 1, 2019, the company said in a statement. Jagdish Mitra, currently the Chief Strategy & Marketing Officer, will take over the responsibility of driving growth of the Enterprise Business.  Manoj Chugh, who is currently the Enterprise Business Head at Tech Mahindra, will take over as President, Corporate Affairs at Mahindra & Mahindra Group. Sanjeev Nikore, currently leading Strategic Initiatives, will now become Head of Marketing at Tech Mahindra. Tech Mahindra shares closed at Rs696.00, up 1.18% on the NSE.

Apple has appealed against a Chinese court ruling that banned the sale and import of most iPhone models after granting Qualcomm an injunction against Apple, a stunning decision that comes amid the trade war between the US and China, CNBC reported. Apple accused Qualcomm of playing dirty tricks, including asserting a patent that had already been invalidated by international courts, and other patents that it had never before used. "Qualcomm's effort to ban our products is another desperate move by a company whose illegal practices are under investigation by regulators around the world," Apple said in a statement on Monday. The ban does not cover the new iPhone XS, iPhone XS Plus or iPhone XR, which were not yet available when Qualcomm, an American microchip maker, filed its lawsuit, CNN reported. The ruling was announced publicly on Monday but put into effect last week, but Apple said in a statement that all iPhone models remain available in China. 

TCS and Singapore Airlines have launched a co-developed solution for Airline industry to digitally transform ground operations. TCS's Intelligent Airline Operations (IAO) solution would help Airlines improve Operational efficiency and enrich customer experience. TCS shares closed at Rs1,998.35, up 1.19% on the BSE.

Cadila Healthcare reported that Liva Pharmaceuticals, its subsidiary, has received the approval from the USFDA (Food and Drug Administration) for its supplemental ANDA - Ranitidine Injection USP. It is used to treat stomach and duodenal (intestinal) ulcers, and prevent them from recurring. The company’s shares closed at Rs346.70, up 1.66% on the BSE. The Total Investment & Insurance Solutions

Dr.Reddy's Laboratories launched the OTC (over the counter) store brand equivalent of Prilosec OTC® - Omeprazole Delayed-Release Tablets in US. It is a proton pump inhibitor used to treat frequent heartburn occurring two or more days per week in adults. The company’s shares closed at Rs2,710.00, up 0.76% on the BSE.

Strides Shasun reported that Vivimed Pte. Ltd, a 50:50 JV (joint venture) of the company in Singapore has received approval from the US FDA for its Albendazole Tablets USP. It is an anthelmintic medication used to treat certain infections caused by tapeworm. The company’s shares closed at Rs458.40, up 6.42% on the BSE.

Lupin has received tentative approval for its Apixaban Tablets from the US FDA to market a generic version of Bristol-Myers Squibb Company's Eliquis® Tablets. The company’s shares closed at Rs835.35, up 2.49% on the BSE.

Titagarh Wagons has been awarded a contract to manufacture and supply of 5,058 Wagons to Indian Railways. These Wagons are BOXN HL type, designed to carry coal, steel, stones etc. and the value of order is Rs1,560.87 crore. The company’s shares closed at Rs71.60, up 7.59% on the BSE. The Total Investment & Insurance Solutions

The top gainers and top losers of the major indices are given in the table below:


The closing values of the major Asian indices are given in the table below: The Total Investment & Insurance Solutions

No comments:

Post a Comment